2. Ministry of Health & Welfare. Incidence Proportion of Major Sites in Korea, 2009. 2009 annual report of cancer statistics in Korea. 2011.
3. Ministry of Health & Welfare. Major cancer sites by age group, 2009. 2009 annual report of cancer statistics in Korea. 2011.
4. Mazzaferri EL. Management of a solitary thyroid nodule. N Engl J Med. 1993. 328(8):553–559.
Article
5. Castro MR, Espiritu RP, Bahn RS, Henry MR, Gharib H, Caraballo PJ, et al. Predictors of malignancy in patients with cytologically suspicious thyroid nodules. Thyroid. 2011. 21(11):1191–1198.
Article
6. Suk JH, Kim TY, Kim MK, Kim WB, Kim HK, Jeon SH, et al. Prevalence of ultrasonographically-detected thyroid nodules in adults without previous history of thyroid disease. J Korean Endocr Soc. 2006. 21(5):389–393.
Article
7. Kim WJ, Kim JH, Park DW, Lee CB, Park YS, Kim DS, et al. Prevalence of thyroid nodules detected by ultrasonography in adults for health check-ups and analysis of fine needle aspiration cytology. J Korean Endocr Soc. 2008. 23(6):413–419.
Article
8. Oh EY, Jang HW, Lee JI, Kim HK, Kim SW, Chung JH. Prevalence of thyroid nodules and cancer detected by ultrasonography in healthy Korean adults: clinical features and the risk for malignancy. J Korean Thyroid Assoc. 2010. 3(2):142–148.
9. Yuen AP, Ho AC, Wong BY. Ultrasonographic screening for occult thyroid cancer. Head Neck. 2011. 33(4):453–457.
Article
10. Berghout A, Wiersinga WM, Smits NJ, Touber JL. Interrelationships between age, thyroid volume, thyroid nodularity, and thyroid function in patients with sporadic nontoxic goiter. Am J Med. 1990. 89(5):602–608.
Article
11. Gharib H, Papini E. Thyroid nodules: clinical importance, assessment, and treatment. Endocrinol Metab Clin North Am. 2007. 36(3):707–735.
Article
12. Tan GH, Gharib H. Thyroid incidentalomas: management approaches to nonpalpable nodules discovered incidentally on thyroid imaging. Ann Intern Med. 1997. 126(3):226–231.
Article
13. Kim DK. Prevalence of thyroid nodules and thyroid cancers. J Korean Thyroid Assoc. 2009. 2(1):38–44.
14. Yim CH, Oh HJ, Chung HY, Han KO, Jang HC, Yoon HK, et al. Prevalence of thyroid nodules detected by ultrasonography in womens attending health check-ups. J Korean Soc Endocrinol. 2002. 17(2):183–188.
15. Chung WY, Chang HS, Kim EK, Park CS. Ultrasonographic mass screening for thyroid carcinoma: a study in women scheduled to undergo a breast examination. Surg Today. 2001. 31(9):763–767.
Article
16. Brander A, Viikinkoski P, Nickels J, Kivisaari L. Thyroid gland: US screening in a random adult population. Radiology. 1991. 181(3):683–687.
Article
17. Ezzat S, Sarti DA, Cain DR, Braunstein GD. Thyroid incidentalomas. Prevalence by palpation and ultrasonography. Arch Intern Med. 1994. 154(16):1838–1840.
Article
18. Faggiano A, Del Prete M, Marciello F, Marotta V, Ramundo V, Colao A. Thyroid diseases in elderly. Minerva Endocrinol. 2011. 36(3):211–231.
19. Morganti S, Ceda GP, Saccani M, Milli B, Ugolotti D, Prampolini R, et al. Thyroid disease in the elderly: sex-related differences in clinical expression. J Endocrinol Invest. 2005. 28:11 Suppl Proceedings. 101–104.
20. Knudsen N, Laurberg P, Perrild H, Bulow I, Ovesen L, Jorgensen T. Risk factors for goiter and thyroid nodules. Thyroid. 2002. 12(10):879–888.
Article
21. Mulla ZD, Margo CE. Primary malignancies of the thyroid: epidemiologic analysis of the Florida Cancer Data System registry. Ann Epidemiol. 2000. 10(1):24–30.
Article
22. Haselkorn T, Stewart SL, Horn-Ross PL. Why are thyroid cancer rates so high in southeast asian women living in the United States? The bay area thyroid cancer study. Cancer Epidemiol Biomarkers Prev. 2003. 12(2):144–150.
23. Belfiore A, La Rosa GL, La Porta GA, Giuffrida D, Milazzo G, Lupo L, et al. Cancer risk in patients with cold thyroid nodules: relevance of iodine intake, sex, age, and multinodularity. Am J Med. 1992. 93(4):363–369.
Article
24. Botrugno I, Lovisetto F, Cobianchi L, Zonta S, Klersy C, Vailati A, et al. Incidental carcinoma in multinodular goiter: risk factors. Am Surg. 2011. 77(11):1553–1558.
Article
25. Toniato A, Bernardi C, Piotto A, Rubello D, Pelizzo MR. Features of papillary thyroid carcinoma in patients older than 75 years. Updates Surg. 2011. 63(2):115–118.
Article
26. Vini L, Hyer SL, Marshall J, A'Hern R, Harmer C. Long-term results in elderly patients with differentiated thyroid carcinoma. Cancer. 2003. 97(11):2736–2742.
Article
27. Girelli ME, Casara D, Rubello D, Mazzarotto R, Saladini G, Busnardo B. Differentiated thyroid carcinoma (DTC) in the elderly: disease outcome, therapeutic approach, and long-term results in a group of 314 patients. J Endocrinol Invest. 1999. 22:10 Suppl. 45–46.
28. Lin JD, Chao TC, Chen ST, Weng HF, Lin KD. Characteristics of thyroid carcinomas in aging patients. Eur J Clin Invest. 2000. 30(2):147–153.
Article
29. Valle LA, Kloos RT. The prevalence of occult medullary thyroid carcinoma at autopsy. J Clin Endocrinol Metab. 2011. 96(1):E109–E113.
Article
30. Kim MJ, Kim JW. Assessment of elderly cancer patients and its clinical importance. Korean J Obstet Gynecol. 2008. 51(7):691–706.
31. Bliss R, Patel N, Guinea A, Reeve TS, Delbridge L. Age is no contraindication to thyroid surgery. Age Ageing. 1999. 28(4):363–366.
Article
32. Passler C, Avanessian R, Kaczirek K, Prager G, Scheuba C, Niederle B. Thyroid surgery in the geriatric patient. Arch Surg. 2002. 137(11):1243–1248.
Article
33. Uruno T, Miyauchi A, Shimizu K, Tomoda C, Takamura Y, Ito Y, et al. Favorable surgical results in 433 elderly patients with papillary thyroid cancer. World J Surg. 2005. 29(11):1497–1501.
Article
34. Biliotti GC, Martini F, Vezzosi V, Seghi P, Tozzi F, Castagnoli A, et al. Specific features of differentiated thyroid carcinoma in patients over 70 years of age. J Surg Oncol. 2006. 93(3):194–198.
Article
35. Matsuyama H, Sugitani I, Fujimoto Y, Kawabata K. Indications for thyroid cancer surgery in elderly patients. Surg Today. 2009. 39(8):652–657.
Article
36. Statistics Korea. Life expectancies, 2010. 2012. [cited 2012 Nov 8]. Available from:
http://kosis.kr.
37. Howell GM, Carty SE, Armstrong MJ, Lebeau SO, Hodak SP, Coyne C, et al. Both BRAF V600E mutation and older age ≥ 65 years) are associated with recurrent papillary thyroid cancer. Ann Surg Oncol. 2011. 18(13):3566–3571.
Article